Sp724

NON INVASIVE TEST FOR COLON CANCER SCREENING SHOULD BE FIRST LINE

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

Review updates and current considerations in colon cancer screening and surveillance related topics. LIVE STREAM SESSION

Tracks

Related Products

Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
Review updates and current considerations in colon cancer screening and surveillance related topics…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA